|
3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid
|
DB01734 |
|
|
Ceruletide
|
DB00403 |
[Caerulein is a specific decapeptide similar in action and composition to the natural gastrointestinal peptide hormone cholecystokinin. It exerts stimulatory effects on the gastric, biliary, and pancreatic secretion, as well as on certain smooth muscles.] |
|
L-Phospholactate
|
DB01733 |
|
|
Eszopiclone
|
DB00402 |
[Eszopiclone, marketed by Sepracor under the brand-name Lunesta, is a nonbenzodiazepine hypnotic drug used to treat insomnia. It is the active stereoisomer of zopiclone, belonging to the class of drugs known as _cyclopyrrolones_.[A179638,L6850] Cyclopyrrolone drugs demonstrate high efficacy and low toxicity[A179827], offering a safer alternative to other drugs used for insomnia.
One major benefit of eszopiclone is that it is approved by the FDA for the long-term treatment of insomnia. This sets it apart from many other hypnotic sedatives, which are generally approved only for the relief of short-term (6-8 weeks) insomnia. Eszopiclone was initially approved by the FDA in 2004.[L6769]] |
|
Dexbrompheniramine
|
DB00405 |
[Dexbrompheniramine maleate is an antihistamine agent that is used for the treatment of allergic conditions, such as hay fever or urticaria.] |
|
[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium
|
DB01736 |
|
|
3-Chloroalaninate
|
DB01735 |
|
|
Alprazolam
|
DB00404 |
[Alprazolam is a triazolobenzodiazepine indicated for the treatment of anxiety and panic disorders.[Label] It is mainly metabolized by CYP3As and so is contraindicated with CYP3A inhibitors like ketoconazole and itraconazole.[Label] Benzodiazepine treatment should be stopped gradually by tapering down a patient's dose to avoid withdrawal symptoms.[A18125] Alprazolam's adverse effects are generally related to the sedation it can cause.[A18125] Alprazolam has been mixed with alcohol as a drug of abuse to potentiate the sedative effects of the drug which may lead to coma and death.[A18125] Alprazolam was given FDA approval on October 16, 1981[L6148].] |
|
(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One
|
DB01732 |
|
|
Nisoldipine
|
DB00401 |
[Nisoldipine is a 1,4-dihydropyridine calcium channel blocker. It acts primarily on vascular smooth muscle cells by stabilizing voltage-gated L-type calcium channels in their inactive conformation. By inhibiting the influx of calcium in smooth muscle cells, nisoldipine prevents calcium-dependent smooth muscle contraction and subsequent vasoconstriction. Nisoldipine may be used in alone or in combination with other agents in the management of hypertension.] |
|
(S)-wiskostatin
|
DB01731 |
|
|
Griseofulvin
|
DB00400 |
[An antifungal antibiotic. Griseofulvin may be given by mouth in the treatment of tinea infections.] |
|
Ciclonicate
|
DB13709 |
|
|
Bis(5-Amidino-Benzimidazolyl)Methane
|
DB01705 |
|
|
2,4-Dihydroxy-Trans Cinnamic Acid
|
DB01704 |
|
|
L-Alfa-Lysophosphatidylcholine, Lauroyl
|
DB01707 |
|
|
2-Bromo-6-chloro-purine
|
DB01706 |
|
|
1,2-Dichloro-Propane
|
DB01701 |
|
|
AICA ribonucleotide
|
DB01700 |
[5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) is an intermediate in the generation of inosine monophosphate and analog of adenosine monophosphate (AMP) that is capable of stimulating AMP-dependent protein kinase (AMPK) activity. AICAR has been used clinically to treat and protect against cardiac ischemic injury. The drug was first used in the 1980s as a method to preserve blood flow to the heart during surgery and is currently of interest as a potential treatment for diabetes by increasing the metabolic activity of tissues by changing the physical composition of muscle.] |
|
N-(2-ferrocenylethyl)maleimide
|
DB01703 |
|
